Anti‐La (SS‐B) but not anti‐Ro52 (SS‐A) antibodies cross‐react with laminin—a role in the pathogenesis of congenital heart block?

• Published in: Clinical and experimental immunology 1995-03, Vol.99 (3), p.316-324
• Main Authors: LI, J.‐M., HORSFALL, A. C., MAINI, R. N.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antibodies, Antinuclear - immunology; Antibody Affinity; autoantibodies; Biological and medical sciences; Blotting, Western; Cardiac dysrhythmias; Cardiology. Vascular system; Cells, Cultured; congenital heart block; Cross Reactions - immunology; cross‐reaction laminin; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fetal Heart - immunology; Fluorescent Antibody Technique; Heart; Heart Block - congenital; Heart Block - immunology; Humans; Immunity, Maternally-Acquired; La/SS‐B; Laminin - immunology; Medical sciences; Middle Aged; Myocardium - immunology
• ISSN: 0009-9104; 1365-2249
• DOI: 10.1111/j.1365-2249.1995.tb05552.x

SUMMARY Cross‐reactions between maternally derived autoantibodies and fetal cardiac antigens have been postulated to play a role in the pathogenesis of congenital heart block (CHB). We have explored the cross‐reactivity of autoantibodies to the small ribonuclear autoantigens, La/SS‐B and Ro/SS‐A, with laminin, the major component of cardiac sarcolemmal membrane using affinity‐purified antibodies from patients with Sjögren's syndrome (SS). Anti‐La antibodies purified from eight of 10 patients cross‐reacted significantly with mouse laminin by ELISA. In contrast, purified antibodies to Ro52 from the same 10 patients showed little or no binding to laminin. Laminin inhibited up to 70% binding of anti‐La antibodies to La antigen, and La inhibited up to 65% binding of anti‐La antibodies to laminin. The cross‐reaction was further examined on cryosections of 10 human fetal hearts aged from 8·7 to 14·9 weeks of gestation, two normal adult hearts, and one pathological adult heart with a diagnosis of dilated cardiomyopathy. Anti‐Ro52 antibodies did not bind to the surface of cardiac cells. However, anti‐La antibodies from seven of 10 patients tested bound to the surface of fetal myocytes from hearts aged 9·4 to 14·9 weeks of gestation, and also to the myocytes from the pathological adult heart but not to normal adult hearts. Preincubation with La antigen abolished the binding of anti‐La antibodies to the surface of adult heart myocytes with dilated cardiomyopathy, and pre‐incubation with mouse laminin could partially block this binding. These results suggest that molecular mimicry between laminin and La, but not Ro52, may act as a target for specific maternal autoantibodies, and contribute to the pathogenesis of CHB at a critical stage during fetal cardiac development.